BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1381836)

  • 1. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
    Hirano T; Manabe T; Tobe T
    Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis.
    Hirano T; Manabe T; Tobe T
    Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein.
    Hirano T; Manabe T; Tobe T
    J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis.
    Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T
    Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
    Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
    Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis.
    Hirano T; Manabe T
    J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307].
    Hirano T; Yotsumoto TM; Ando K; Tobe T
    Nihon Geka Hokan; 1991 Sep; 60(5):342-53. PubMed ID: 1726453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of gabexate mesilate (FOY) against impaired pancreatic energy metabolism in rat acute pancreatitis induced by caerulein.
    Hirano T; Manabe T; Tobe T
    Life Sci; 1991; 49(22):PL179-84. PubMed ID: 1719326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats.
    Hirano T; Manabe T; Steer M; Printz H; Calne R; Tobe T
    Surg Gynecol Obstet; 1993 Apr; 176(4):371-81. PubMed ID: 8460415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
    Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T
    Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123.
    Hirano T; Manabe T; Yotsumoto F; Ohshio G; Nio Y
    Nihon Geka Hokan; 1992 May; 61(3):234-48. PubMed ID: 1280076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of lysosomal and digestive enzymes in rat caerulein pancreatitis].
    Hirano T; Manabe T; Imanishi K; Tobe T
    Nihon Geka Hokan; 1991 Mar; 60(2):122-34. PubMed ID: 1726396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate].
    Hirano T; Manabe T; Tobe T
    Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of parotid gland in rat caerulein-induced acute pancreatitis: study on in vitro system].
    Hirano T; Manabe T; Tobe T
    Nihon Geka Hokan; 1990 Jul; 59(4):310-4. PubMed ID: 1718233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular alterations of parotid gland of rats with acute pancreatitis induced by cerulein.
    Hirano T; Manabe T; Tobe T
    Int J Pancreatol; 1991; 10(3-4):217-27. PubMed ID: 1724007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of short-termed pancreatic duct obstruction on the pancreatic subcellular organellar fragility and pancreatic lysosomal enzyme secretion in rabbits.
    Hirano T; Manabe T
    Scand J Clin Lab Invest; 1992 Oct; 52(6):523-35. PubMed ID: 1384108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of camostat mesilate and allopurinol in acute edematous pancreatitis in the rat induced by excessive doses of caerulein].
    Yamasaki Y; Kuroshima T; Tsuji K; Kawamoto H; Higashimoto Y
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jul; 84(7):1498. PubMed ID: 3682249
    [No Abstract]   [Full Text] [Related]  

  • 18. Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis.
    Ohshio G; Saluja AK; Leli U; Sengupta A; Steer ML
    Gastroenterology; 1989 Mar; 96(3):853-9. PubMed ID: 2464526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of gabexate mesilate on acute pancreatitis induced by tacrolimus (FK-506) in rats in which the pancreas was stimulated by caerulein.
    Ito T; Kimura T; Furukawa M; Yamaguchi H; Goto M; Nakano I; Nawata H
    J Gastroenterol; 1994 Jun; 29(3):305-13. PubMed ID: 7520321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prostaglandin E on the redistribution of lysosomal enzymes in caerulein-induced pancreatitis.
    Hirano T; Manabe T; Yotsumoto F; Ando K; Imanishi K; Tobe T
    Hepatogastroenterology; 1993 Apr; 40(2):155-8. PubMed ID: 7685311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.